About: Efficacy and tolerance of dasatinib after imatinib failure or intolerance for chronic myeloid leukemia patients treated in three different hospitals compare well with results achievable in formal clinical trials

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Efficacy and tolerance of dasatinib after imatinib failure or intolerance for chronic myeloid leukemia patients treated in three different hospitals compare well with results achievable in formal clinical trials Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
rdfs:seeAlso	http://informahealthcare.com/doi/abs/10.3109/10428194.2013.772173
Description	We have confirmed both the efficacy and safety of dasatinib in patients with CML in different stages when generally treated outside of clinical trials. Well-managed centralized care of patients with CML permits treatment event monitoring and composite endpoint analyses, such as FFS, TFFS or ATFS, which can reveal particular therapy status in a more detailed and realistic manner. We have confirmed both the efficacy and safety of dasatinib in patients with CML in different stages when generally treated outside of clinical trials. Well-managed centralized care of patients with CML permits treatment event monitoring and composite endpoint analyses, such as FFS, TFFS or ATFS, which can reveal particular therapy status in a more detailed and realistic manner. (en)
Title	Efficacy and tolerance of dasatinib after imatinib failure or intolerance for chronic myeloid leukemia patients treated in three different hospitals compare well with results achievable in formal clinical trials Efficacy and tolerance of dasatinib after imatinib failure or intolerance for chronic myeloid leukemia patients treated in three different hospitals compare well with results achievable in formal clinical trials (en)
skos:prefLabel	Efficacy and tolerance of dasatinib after imatinib failure or intolerance for chronic myeloid leukemia patients treated in three different hospitals compare well with results achievable in formal clinical trials Efficacy and tolerance of dasatinib after imatinib failure or intolerance for chronic myeloid leukemia patients treated in three different hospitals compare well with results achievable in formal clinical trials (en)
skos:notation	RIV/00023736:_____/13:00010706!RIV14-MZ0-00023736
http://linked.open...avai/riv/aktivita	V
http://linked.open...avai/riv/aktivity	V
http://linked.open...iv/cisloPeriodika	10
http://linked.open...vai/riv/dodaniDat	2014
http://linked.open...aciTvurceVysledku	Cetkovský, Petr Klamová, Hana Machová Poláková, Kateřina
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Ústav hematologie a krevní transfúze
http://linked.open...dnocenehoVysledku	72019
http://linked.open...ai/riv/idVysledku	RIV/00023736:_____/13:00010706
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	cytogenetic response; dasatinib; high-dose imatinib; survival; ABL protein (en)
http://linked.open.../riv/klicoveSlovo	cytogenetic response ABL protein high-dose imatinib survival dasatinib
http://linked.open...odStatuVydavatele	GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV	[323A6DFED531]
http://linked.open...i/riv/nazevZdroje	Leukemia & lymphoma
http://linked.open...in/vavai/riv/obor	FD
http://linked.open...ichTvurcuVysledku	3 (xsd:int)
http://linked.open...cetTvurcuVysledku	12 (xsd:int)
http://linked.open...UplatneniVysledku	2013
http://linked.open...v/svazekPeriodika	54
http://linked.open...iv/tvurceVysledku	Cetkovský, Petr Dušek, L. Dvořáková, D. Klamová, Hana Mayer, J. Ráčil, Z. Rázga, F. Machová Poláková, Kateřina Jurček, T. Mužík, J. Žáčková, D. Cmunt, E.
http://linked.open...ain/vavai/riv/wos	000324589800042
issn	1042-8194
number of pages	4 (xsd:int)
http://bibframe.org/vocab/doi	10.3109/10428194.2013.772173

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 67 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software